BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240813
DTEND;VALUE=DATE:20240814
DTSTAMP:20260413T063804
CREATED:20240731T163455Z
LAST-MODIFIED:20240815T173703Z
UID:5838-1723507200-1723593599@www.immunologypodcast.com
SUMMARY:Dr. Adrian Erlebacher
DESCRIPTION:Dr. Adrian Erlebacher is a Professor in the Department of Laboratory Medicine at the University of California San Francisco. His research lies at the intersection of immunology and developmental biology. In particular\, his lab is interested in how the developmental properties of a tissue influence its ability to mount a successful immune response\, and\, conversely\, how cells of the immune system influence tissue development and remodeling. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-adrian-erlebacher
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/07/Adrian-Erlebacher-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240827
DTEND;VALUE=DATE:20240828
DTSTAMP:20260413T063804
CREATED:20240822T042356Z
LAST-MODIFIED:20240827T173454Z
UID:5866-1724716800-1724803199@www.immunologypodcast.com
SUMMARY:Dr. Kipp Weiskopf
DESCRIPTION:Dr. Kipp Weiskopf is a Valhalla Fellow at the Whitehead Institute. Dr. Weiskopf’s lab studies novel macrophage and myeloid immune checkpoints. Weiskopf began studying the CD47/SIRP⍺ interaction as a graduate student and demonstrated that CD47-blocking therapies could unleash immune attack against cancer and enhance a number of existing therapies. He also showed they could be used to treat small cell lung cancer and might permit bone marrow transplantation without using chemotherapy or radiation. The Weiskopf lab studies additional mechanisms that control myeloid cell activation in tumors to develop new treatments for cancer and other life-threatening diseases\, such as COVID-19.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kipp-weiskopf
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/kipp-weiskopf-420-px.jpg
END:VEVENT
END:VCALENDAR